Concurrent Guillain-Barré syndrome and longitudinally extensive myelopathy secondary to SARS-CoV-2 infection. Case report
Concurrent Guillain-Barré syndrome and longitudinally extensive myelopathy secondary to SARS-CoV-2 infection. Case report
Cómo citar
Descargar cita
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Mostrar biografía de los autores
Artículos más leídos del mismo autor/a
- Daniela Duque Montoya, Fabio Andres Sepulveda Collazos, Esteban Echeverri López, Encefalitis hemorrágica como manifestación primaria de granulomatosis linfomatoide: reporte de un caso , Archivos de Medicina (Manizales): Vol. 24 Núm. 1 (2024): .
Introduction: The severe acute respiratory syndrome caused by the virus SARS-CoV-2 may have a wide range of neurological manifestations. Guillain-Barré syndrome (GBS) is a post-infectious acute polyneuropathy characterized by symmetrical and ascending flaccid paralysis, described as a complication of SARS-CoV-2 infection and other pathogens. Inflammatory myelopathies associated with the virus have been also described, among which transverse myelitis is frequent. Outstanding the autoinflammatory characteristics of both entities, there is the possibility of concurrent presentation.
Case description: a 23-year-old male consulted due to pain and ascending acute weakness syndrome in the lower limbs with the impossibility for urination and defecation over a 4-day course. The diagnosis of Guillain Barrè was made by electromyography, a thoracolumbar magnetic resonance was performed, with findings of longitudinally extensive inflammatory myelopathy. An antibody test for SARS-CoV-2 was performed on cerebrospinal fluid with a positive IgG result, considering neurological compromise because of the virus. Management was done with plasmapheresis and methylprednisolone pulses, with a favorable response and hospital discharge.
Discussion: the compromise of SARS-CoV-2 in the central and peripheral nervous system is known. Pathologies such as Guillain Barrè syndrome have been widely reported and studied as a consequence of SARS-CoV-2 infection, also exist a variety of reports of longitudinally extensive inflammatory myelopathy associated with the pathogen, however, the concurrence between both pathologies has been scarcely reported.
Conclusions: It is necessary to consider the wide variety of atypical presentations, and even confluent ones, caused by infectious agents such as SARS-CoV-2, to achieve timely diagnosis and management that reduce morbidity and mortality in patients.
Visitas del artículo 265 | Visitas PDF 217
Descargas
- 1. Liu K, Pan M, Xiao Z, Xu X. Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019–2020. J Neurol Neurosurg Psychiatry. 2020;91:669–70. 2. Sheikh AB, Chourasia PK, Javed N, Chourasia MK, Suriya SS, Upadhyay S, et al. Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review. J Neuroimmunol. 2021;355:577577. 3. Ahmad SA, Salih KH, Ahmed SF, Kakamad FH, Salh AM, Hassan MN, et al. Post COVID-19 transverse myelitis; a case report with review of literature. Ann Med Surg (Lond). 2021;69:102749. 4. Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic Alterations Due to Respiratory Virus Infections. Front Cell Neurosci. 2018;12:386. 5. Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168–75. 6. Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol (Paris). 2021;177:51–64. 7. Solomon T. Neurological infection with SARS-CoV-2 — the story so far. Nat Rev Neurol. 2021;17:65–6. 8. Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol. 2021;350:577436. 9. Halpert G, Shoenfeld Y. SARS-CoV-2, the autoimmune virus. Autoimmun Rev. 2020;19:102695. 10. Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol. 2022;94:54–62. 11. Wakerley BR, Yuki N. Infectious and noninfectious triggers in Guillain–Barré syndrome. Expert Review of Clinical Immunology. 2013;9:627–39. 12. Panda PK, Sharawat IK, Panda P, Natarajan V, Bhakat R, Dawman L. Neurological Complications of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis. Journal of Tropical Pediatrics. 2021;67:fmaa070. 13. Palaiodimou L, Stefanou M, Katsanos AH, Fragkou PC, Papadopoulou M, Moschovos C, et al. Prevalence, clini-cal characteristics and outcomes of Guillain−Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol. 2021;28:3517–29. 14. Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268:1133–70. 15. Wang F, Wang D, Wang Y, Li C, Zheng Y, Guo Z, et al. Population-Based Incidence of Guillain-Barré Syndrome During Mass Immunization With Viral Vaccines: A Pooled Analysis. Front Immunol. 2022;13:782198. 16. Aladawi M, Elfil M, Abu-Esheh B, Abu Jazar D, Armouti A, Bayoumi A, et al. Guillain Barre Syndrome as a Com-plication of COVID-19: A Systematic Review. Can J Neurol Sci. 2022;49:38–48. 17. Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol. 2019;15:671–83. 18. Artemiadis A, Liampas A, Hadjigeorgiou L, Zis P. Myelopathy associated with SARS-COV-2 infection. A systematic review. Neurological Research. 2021;43:633–41. 19. Mondal R, Deb S, Shome G, Ganguly U, Lahiri D, Benito-León J. COVID-19 and emerging spinal cord complica-tions: A systematic review. Multiple Sclerosis and Related Disorders. 2021;51:102917. 20. Schulte EC, Hauer L, Kunz AB, Sellner J. Systematic review of cases of acute myelitis in individuals with CO-VID-19. Eur J Neurol. 2021;28:3230–44. 21. Lee G. Acute longitudinal extensive transverse myelitis secondary to asymptomatic SARS-CoV-2 infection. BMJ Case Rep. 2021;14:e244687. 22. Canavero I, Ravaglia S, Valentino F, Micieli G. Guillain Barrè syndrome and myelitis associated with SARS-CoV-2 infection. Neuroscience Letters. 2021;759:136040. 23. Alrubaye R, Bondugula V, Baleguli V, Chofor R. A possible Guillain-Barré syndrome/transverse myelitis overlap syndrome after recent COVID-19. BMJ Case Rep. 2022;15:e246967. 24. Khera D, Didel S, Panda S, Tiwari S, Singh K. Concurrent Longitudinally Extensive Transverse Myelitis and Guillain-Barré Syndrome in a Child Secondary to COVID-19 Infection: A Severe Neuroimmunologic Complication of COVID-19. Pediatric Infectious Disease Journal. 2021;40:e236–9.
Información
